Cargando…
Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis
Currently, whether the impact of age on efficacy of molecular targeted agents (MTAs) in the treatment of hepatocellular carcinoma (HCC) patients remains undetermined. We searched databases and abstracts presented at ASCO meeting to identify relevant studies. The endpoints were overall survival (OS)...
Autores principales: | Du, Jing, Mao, Ye, Liu, Ming, Tie, Yan, Huang, Hai, Zhao, Jian, Xiang, Zhongzheng, Luo, Di |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731966/ https://www.ncbi.nlm.nih.gov/pubmed/29254256 http://dx.doi.org/10.18632/oncotarget.22061 |
Ejemplares similares
-
Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic review
por: Li, Xiaofei, et al.
Publicado: (2017) -
Molecular targeted agents as second-line treatment for hepatocellular carcinoma: a meta-analysis and review
por: Kim, Jung Han, et al.
Publicado: (2017) -
Efficacy and safety of laparoscopic pyelolithotomy versus
percutaneous nephrolithotomy for treatment of large renal stones: a
meta-analysis
por: Mao, Tie, et al.
Publicado: (2021) -
Low-Dose NOACs Versus Standard-Dose NOACs or Warfarin on Efficacy and Safety in Asian Patients with NVAF: A Meta-Analysis
por: Li, Ze, et al.
Publicado: (2022) -
Efficacy and safety of anti-vascular endothelial growth factor agents on corneal neovascularization: A meta-analysis
por: Lai, Shih-Chung, et al.
Publicado: (2023)